Cargando…
Recent progress in the treatment for unresectable biliary tract cancer
Recent changes in the treatment of unresectable BTC have been remarkable. More recently, triple combination therapy with GC and S‐1 (GCS) and GC and nab‐Paclitaxel was used. Also, immune checkpoint inhibitors have been increasingly used for BTC.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319608/ https://www.ncbi.nlm.nih.gov/pubmed/37416743 http://dx.doi.org/10.1002/ags3.12710 |
| _version_ | 1785068273629396992 |
|---|---|
| author | Endo, Itaru |
| author_facet | Endo, Itaru |
| author_sort | Endo, Itaru |
| collection | PubMed |
| description | Recent changes in the treatment of unresectable BTC have been remarkable. More recently, triple combination therapy with GC and S‐1 (GCS) and GC and nab‐Paclitaxel was used. Also, immune checkpoint inhibitors have been increasingly used for BTC. |
| format | Online Article Text |
| id | pubmed-10319608 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103196082023-07-06 Recent progress in the treatment for unresectable biliary tract cancer Endo, Itaru Ann Gastroenterol Surg Editorial Recent changes in the treatment of unresectable BTC have been remarkable. More recently, triple combination therapy with GC and S‐1 (GCS) and GC and nab‐Paclitaxel was used. Also, immune checkpoint inhibitors have been increasingly used for BTC. John Wiley and Sons Inc. 2023-06-29 /pmc/articles/PMC10319608/ /pubmed/37416743 http://dx.doi.org/10.1002/ags3.12710 Text en © 2023 The Author. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Endo, Itaru Recent progress in the treatment for unresectable biliary tract cancer |
| title | Recent progress in the treatment for unresectable biliary tract cancer |
| title_full | Recent progress in the treatment for unresectable biliary tract cancer |
| title_fullStr | Recent progress in the treatment for unresectable biliary tract cancer |
| title_full_unstemmed | Recent progress in the treatment for unresectable biliary tract cancer |
| title_short | Recent progress in the treatment for unresectable biliary tract cancer |
| title_sort | recent progress in the treatment for unresectable biliary tract cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319608/ https://www.ncbi.nlm.nih.gov/pubmed/37416743 http://dx.doi.org/10.1002/ags3.12710 |
| work_keys_str_mv | AT endoitaru recentprogressinthetreatmentforunresectablebiliarytractcancer |